Key Stats for Johnson & Johnson StockPrice change for Johnson & Johnson stock in last 6 months: 14%$JNJ Stock Price as of Oct. 22: $26752-Week High: $281$JNJ Stock Price Target: $279__Now Live: ...
6d
Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy.
Wise investors, however, will view this pullback from J&J shares as an opportunity rather than an omen. Although the company ...
Johnson & Johnson has been dealing for years with thousands of lawsuits related to its talc-based products, which plaintiffs claim gave them cancer. This issue has somewhat affected the drugmaker's ...
MedTech growth stalled while pharma surged, leaving the company to bet on new product launches and a planned spin-off to ...
A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc products cause ...
Johnson & Johnson is downgraded to a Hold, citing mixed fundamentals and regulatory headwinds. Read more on JNJ stock here.
Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer on Thursday told investors why he thinks the stock of Johnson & Johnson is performing well this year even as the broader healthcare sector lags.
Monday - Friday, 6:00 - 7:00 PM ET As Wall Street navigates a jam-packed start to earnings season, CNBC's Jim Cramer explained what made shares of Johnson & Johnson rise after the company posted its ...
Add Yahoo as a preferred source to see more of our stories on Google. On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked ...
Today, Johnson & Johnson released its financial results for Q3 2025, which once again stunned Wall Street. So, sales of Rybrevant/Lazcluze, the 'diamond' in its oncology franchise, reached $198 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results